Human-relevant organ-on-chip system enabling personalized drug screening and rapid clinical trials, reducing dependence on animal testing with accurate human models.
We develop human-relevant Organ-On-Chip technology that enables personalized drug screening and accelerates clinical trials. Our platform replaces animal testing with accurate human models, predicting patient-specific treatment outcomes, reducing development costs and time, and increasing clinical success rates. We aim to transform precision medicine and revolutionize the global drug testing ecosystem.
1. Startup India Seed Fund - 10 L 2. BRIAC - 50 L 3. Nidhi Priyas - 8 L 4. Angel Investment - 1 Cr
4 patents
Accreditations include the Innovation and Technology Award from the Department of Pharma and FICCI (G20, Gujarat). The work has been recognized by the Ministry of Education, MIT, USA (for growing tiny brains in a 3D-printed bioreactor), The New Indian Express, and The Economic Times. The research has been featured in a journal and resulted in over 200 press releases globally.
Professor Shantanu Pradhan, a biotechnology expert at IIT Madras, is a key asset to the team.
Director
